KIRALDA

This brand name is authorized in Lithuania

Active ingredients

The drug KIRALDA contains one active pharmaceutical ingredient (API):

1 Gadobutrol
UNII 1BJ477IO2L - GADOBUTROL

Gadobutrol is a gadolinium-based, hydrophilic, macrocyclic, electrically neutral contrast agent used in contrast-enhanced MRI (CE-MRI).

Read about Gadobutrol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V08CA09 Gadobutrol V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1089233, 1089234, 1089235, 1089236, 1089237, 1089238, 1089239, 1089240, 1089241, 1089242, 1089243, 1089244, 1089245, 1089246, 1089247, 1089248

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈